Randomized Phase 2 Trial of Autologous Platelet-Rich Plasma Plus Extracellular Matrix for Chronic Ulcer Wound Healing

Phase 2, randomised trial of autologous platelet-rich plasma in arterial ulcer and stasis ulcer (3 arms), sponsored by University Hospital Ostrava. Primary endpoints: Number of local adverse events in each arm over 12 weeks and Efficacy of aPRP + ECM vs ECM alone vs control on chronic wound healing. Started Jul 2013; status: completed.